Main menu

Post navigation

For these children/youth, if they are admitted to hospital at the

For these children/youth, if they are admitted to hospital at their index ED visit we will complete Gemcitabine FDA at CPTT to look for ‘triggers’ in their record. For all children/youth in this group, we will also examine the electronic health record to determine whether the patient had a visit to the ED or admission in the 21 days following their index visit. If they are determined

to have had a subsequent ED visit or admission, these patients will be considered to have flagged outcomes. Any patient with a flagged outcome or trigger will have their medical record will be reviewed (see stage 2 below) for an AE. Preparation of case summaries Any patient deemed to have a flagged outcome on telephone follow-up or a trigger on medical record review will have a case summary prepared by a research nurse. We will orient each site’s research nurse on case summary creation. The case summaries are intended as narrative descriptions of what occurred at the index ED visit and the outcome. This technique is used in order to reduce the risk of handwriting recognition by examining the health record itself. These summaries will include: (1) patient demographics; (2) index

ED visit details (such as date of visit, presenting complaint, vital signs, history of presenting illness, physical examination, investigations, treatment, etc.); (3) flagged outcome/trigger details (such as description of symptoms, date of return visits, ED visit details, and discharge or death summary details). Copies of the index ED visit, subsequent ED visits, discharge summary or death summary, as well as laboratory and other investigations (such as ECG and chest X-ray reports) will be accessible to the physician reviewers as required and will be de-identified. Stage 2: identification of AEs After standardised, comprehensive training, three ED physicians will independently review the case summary of each patient. They will then complete a computerised structured outcome assessment form. These reviewers will be blinded to patient name

and sex, date and time of visit, treating physician, and study site. If the reviewers are unable to make their AE determinations based on the narrative case summary alone, they will have access to the key components of the medical record used in creating the case AV-951 summary (blinded as outlined above). The reviewers will then be asked to independently determine whether the flagged outcome or trigger may be associated with healthcare management and rate their certainty of this determination on a six-point Likert scale used in previous studies (see online supplementary appendix 1).4 6 7 12 13 29 On this six-point Likert scale, 1 represents a flagged outcome or trigger was most certainly due to disease and 6 represents that it was most certainly due to care. If two reviewers have a level of certainty ≥4, the outcome will be classified as an AE.